DANA PRESTON: Open Payments
NPI 1861699225 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 43 payments from 16 companies in 2025. Trend: 2023 $2,575 · 2024 $2,123 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $248 |
| AstraZeneca Pharmaceuticals LP | 4 | $160 |
| Amgen Inc. | 8 | $150 |
| GlaxoSmithKline, LLC. | 2 | $148 |
| ABBVIE INC. | 2 | $143 |
| Abbott Laboratories | 4 | $86 |
| Lilly USA, LLC | 3 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
Products named: Wegovy, VRAYLAR, AREXVY, FARXIGA, REPATHA, FREESTYLE LIBRE 3, JARDIANCE, MOUNJARO.
Industry payments across FL — which companies pay providers there.
